Heather Swift,
This Viewpoint discusses the implications of the US FDA’s 2018 marketing authorization permitting 23and Me to market BRCA…
This Viewpoint discusses the implications of the US FDA’s 2018 marketing authorization permitting 23and Me to market BRCA…
This Viewpoint discusses the implications of the US FDA’s 2018 marketing authorization permitting 23and Me to market BRCA…
This Viewpoint discusses the implications of the US FDA’s 2018 marketing authorization permitting 23and Me to market BRCA…
DTC Testing for #BRCA has the potential to transform the field of genetic testing, but as with many new medical innovations, it…